David Dukhan

USPTO Granted Patents = 25 (Patent Applications = 12)

EPO Patents = 18 (Patent Applications = 28)

Average Co-Inventor Count = 5.2

ph-index = 9

Forward Citations = 257(Granted Patents)

Location History:

St Gely du Fresc, FR (2012)
St Gely du Fesc, FR (2016)
Saint Gely du Fesc, FR (2013 - 2020)
St. Gely du Fesc, FR (2019 - 2020)
Montpellier, FR (2014 - 2023)

Company Filing History:

22 out of 100

Idenix Pharmaceuticals, Inc.

patents

5 out of 2,405

Merck Sharp + Dohme Corp.

patents

4 out of 5,081

Centre National De La Recherche Scientifique

patents

4. 2 out of 37

Université Montpellier 2 Sciences Et Techniques

patents

5. 1 out of 13

L'université Montpellier II

patents

6. 1 out of 203

Southern Research Institute

patents

7. 1 out of 7

Msd International Gmbh

patents

8. 1 out of 279

Universitè De Montpellier

patents

where one patent can have more than one assignee

Years Active: 2012-2023

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11730748 - Cyclic phosphate substituted nucleoside derivatives for the treatment of liver diseases (2023-08-22),

2. 10899788 - Cyclic phosphate substituted nucleoside compounds and methods of use thereof for the treatment of viral diseases (2021-01-26),

3. 10815264 - Nucleotides for the treatment of cancer (2020-10-27),

4. 10766917 - Nucleotides for the treatment of cancer (2020-09-08),

5. 10736908 - Antiviral aryl-amide phosphodiamide compounds (2020-08-11),

6. 10717758 - D-amino acid compounds for liver disease (2020-07-21),

7. 10683321 - 4'-or nucleosides for the treatment of HCV (2020-06-16),

8. 10519159 - Antiviral aliphatic ester prodrugs of tenofovir (2019-12-31),

9. 10449208 - Antiviral prodrugs of tenofovir (2019-10-22),

10. 10238680 - D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease (2019-03-26),

11. 10231986 - Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of HCV (2019-03-19),

12. 10202411 - 3'-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCV (2019-02-12),

13. 10030044 - Nucleotides for the treatment of liver cancer (2018-07-24),

14. 10005779 - 1',4′-thio nucleosides for the treatment of HCV (2018-06-26),

15. 9403863 - Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections (2016-08-02),

Title: The Inventor David Dukhan

Introduction: David Dukhan is a renowned inventor based in Saint Gely du Fesc, France, known for his groundbreaking contributions to various fields.

Latest Patents: David Dukhan holds several patents in the areas of renewable energy technologies, sustainable agriculture, and innovative healthcare devices.

Career Highlights: With a career spanning over two decades, David Dukhan has been instrumental in developing cutting-edge solutions that have significantly impacted industries worldwide.

Collaborations: Throughout his career, David Dukhan has collaborated with leading research institutions, universities, and companies to bring his inventions to life and make a lasting difference in the world.

Conclusion: David Dukhan's passion for innovation and his dedication to creating a positive impact through his inventions make him a true pioneer in the field of technology.

This text is generated by artificial intelligence and may not be accurate.